Today a CIRM-funded disease team working toward a therapy for type 1 diabetes received additional support and endorsement from the Juvenile Diabetes Research Foundation (JDRF). The project, led by San Diego-based Viacyte, received almost $20 million in funding from CIRM in October 2009.The goal of the ViaCyte project is to mature embryonic stem cells into … Continue reading JDRF supports CIRM diabetes disease team led by ViaCyte

On December 8 of last year, CIRM received the insights and recommendations from a blue ribbon panel of external experts charged with evaluating the agency’s progress to date. (Here is a copy of that report, and CIRM’s press release.)Less than a year later, on October 26, 2011 the ICOC approved the first of a three-part … Continue reading Opportunity Fund addresses review panel’s recommendations